![](/img/cover-not-exists.png)
Daily (QD) v twice-daily (BID) thoracic irradiation (TI) with concurrent cisplatin-etoposide (PE) for limited small cell lung cancer (LSCLC). Preliminary results on 352 randomized eligible patients
Volume:
11
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/0169-5002(94)94440-7
Date:
June, 1994
File:
PDF, 174 KB
english, 1994